Učitavanje...
TAT‐GDNF in Neurodegeneration and Ischemic Stroke
The delivery of proteins across the blood‐brain barrier is severely limited by their size and biochemical properties. Numerous peptides have been characterized in recent years that prevent neuronal death in vitro, but cannot be used therapeutically, since they do not cross cell membrane barriers. It...
Spremljeno u:
| Izdano u: | CNS Drug Rev |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Blackwell Publishing Ltd
2006
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741709/ https://ncbi.nlm.nih.gov/pubmed/16614736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2005.tb00054.x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|